Journal
DIABETIC MEDICINE
Volume 32, Issue 1, Pages 85-89Publisher
WILEY
DOI: 10.1111/dme.12608
Keywords
-
Categories
Funding
- Skaraborg Research and Development Council, Skaraborg
- Primary Care Research and Development Council, Skane
- European Research Council [StG-282255]
- Swedish Medical Research Council
- Swedish Heart and Lung Foundation
- Medical Faculty of Lund University
- Skane University Hospital
- Novo Nordisk Foundation
- Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish
Ask authors/readers for more resources
Aim To study the prognosis of patients with newly diagnosed Type 2 diabetes in primary care in relation to their baseline C-peptide concentration. Methods C-peptide concentrations were determined in 399 patients aged < 65 years with newly diagnosed Type 2 diabetes using the Skaraborg Diabetes Register, Sweden. Data on cardiovascular complications and death were extracted from national registers and a local study of retinopathy. Statistical analyses were performed using Cox regression. Results An analysis of C-peptide concentrations in quartiles, after adjusting for confounders, showed that patients in the highest quartile had a 2.75-fold higher risk of death from all causes compared with those in the lowest quartile (CI 1.17-6.47). By contrast, C-peptide concentration was not associated with the incidence of cardiovascular events or the development of retinopathy. Conclusions Measurement of C-peptide concentration at diagnosis could help identify patients who are at high risk and who presumably would benefit from more intensive treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available